The following arguments should be considered in the decision on which approach to use for the treatment of SCD: in our studies, ABE8e-NRCH was more effective in installing the corrective mutation in human CD34+ cells than PE5max in vitro studies. This evidence concerns the gene CD34 and Schnyder corneal dystrophy.